Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Collegium Pharmaceutical Inc

COLL
Current price
35.4 USD +0.37 USD (+1.06%)
Last closed 35.14 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 1 167 920 512 USD
Yield for 12 month +52.78 %
1Y
3Y
5Y
10Y
15Y
COLL
21.11.2021 - 28.11.2021

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts. Address: 100 Technology Center Drive, Stoughton, MA, United States, 02072

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

40 USD

P/E ratio

27.6822

Dividend Yield

Current Year

+566 767 000 USD

Last Year

+463 933 000 USD

Current Quarter

+149 745 000 USD

Last Quarter

+136 709 000 USD

Current Year

+326 169 000 USD

Last Year

+209 488 000 USD

Current Quarter

+94 630 000 USD

Last Quarter

+80 311 000 USD

Key Figures COLL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 339 832 992 USD
Operating Margin TTM 41.2 %
PE Ratio 27.6822
Return On Assets TTM 10.28 %
PEG Ratio
Return On Equity TTM 24.68 %
Wall Street Target Price 40 USD
Revenue TTM 566 766 976 USD
Book Value 6.13 USD
Revenue Per Share TTM 16.8 USD
Dividend Share
Quarterly Revenue Growth YOY 15.5 %
Dividend Yield
Gross Profit TTM 345 743 000 USD
Earnings Share 1.29 USD
Diluted Eps TTM 1.29 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY 5197.6 %
Profit Margin 8.5 %

Dividend Analytics COLL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History COLL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation COLL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 27.6822
Forward PE 5.7837
Enterprise Value Revenue 2.7042
Price Sales TTM 2.0607
Enterprise Value EBITDA 4.9708
Price Book MRQ 5.9812

Financials COLL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators COLL

For 52 weeks

20.83 USD 40.95 USD
50 Day MA 36.59 USD
Shares Short Prior Month 7 009 711
200 Day MA 27.99 USD
Short Ratio 14.17
Shares Short 7 118 018
Short Percent 26.89 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

414.58 USD Microsoft Corporation +0.12 (+0.03%)
Detailed analytics

ETF funds


M

MDAXEX

208.70 CHF iShares MDAX UCITS ETF (DE) -11.84 (-4.92%)
Detailed analytics

Metals


Gold

2169.94 USD Gold -5.94 (-0.27%)
Detailed analytics